Otello Stampacchia - Net Worth and Insider Trading

Otello Stampacchia Net Worth

The estimated net worth of Otello Stampacchia is at least $99 Million dollars as of 2024-05-16. Otello Stampacchia is the Director, 10% Owner of Morphic Holding Inc and owns about 2,969,582 shares of Morphic Holding Inc (MORF) stock worth over $90 Million. Otello Stampacchia is the CEO, 10% Owner of Omega Alpha SPAC and owns about 501,000 shares of Omega Alpha SPAC (OMEG) stock worth over $5 Million. Otello Stampacchia is also the Director, 10% Owner of Kronos Bio Inc and owns about 3,818,283 shares of Kronos Bio Inc (KRON) stock worth over $4 Million. Details can be seen in Otello Stampacchia's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Otello Stampacchia has not made any transactions after 2021-01-11 and currently still holds the listed stock(s).

Transaction Summary of Otello Stampacchia

To

Otello Stampacchia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Otello Stampacchia owns 13 companies in total, including Kronos Bio Inc (KRON) , Morphic Holding Inc (MORF) , and Replimune Group Inc (REPL) among others .

Click here to see the complete history of Otello Stampacchia’s form 4 insider trades.

Insider Ownership Summary of Otello Stampacchia

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2020-10-14 director & 10 percent owner
MORF Morphic Holding Inc 2020-12-23 director
REPL Replimune Group Inc 2018-07-19 director & 10 percent owner
2019-09-05 director & 10 percent owner
2019-04-12 10 percent owner
2018-07-02 10 percent owner
2018-06-20 10 percent owner
2014-10-30 10 percent owner
2021-10-06 10 percent owner
2021-02-10 10 percent owner
2021-01-11 director & 10 percent owner & Chief Executive Officer
2021-03-25 director
2023-11-02 10 percent owner

Otello Stampacchia Latest Holdings Summary

Otello Stampacchia currently owns a total of 3 stocks. Among these stocks, Otello Stampacchia owns 2,969,582 shares of Morphic Holding Inc (MORF) as of July 1, 2019, with a value of $90 Million and a weighting of 91.07%. Otello Stampacchia owns 501,000 shares of Omega Alpha SPAC (OMEG) as of January 11, 2021, with a value of $5 Million and a weighting of 5.13%. Otello Stampacchia also owns 3,818,283 shares of Kronos Bio Inc (KRON) as of October 14, 2020, with a value of $4 Million and a weighting of 3.8%.

Latest Holdings of Otello Stampacchia

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MORF Morphic Holding Inc 2019-07-01 2,969,582 30.23 89,770,464
OMEG Omega Alpha SPAC 2021-01-11 501,000 10.10 5,060,100
KRON Kronos Bio Inc 2020-10-14 3,818,283 0.98 3,747,263

Holding Weightings of Otello Stampacchia


Otello Stampacchia Form 4 Trading Tracker

According to the SEC Form 4 filings, Otello Stampacchia has made a total of 1 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Morphic Holding Inc is the acquisition of 133,333 shares on July 1, 2019, which cost Otello Stampacchia around $2 Million.

According to the SEC Form 4 filings, Otello Stampacchia has made a total of 1 transactions in Omega Alpha SPAC (OMEG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Omega Alpha SPAC is the acquisition of 501,000 shares on January 11, 2021, which cost Otello Stampacchia around $5 Million.

According to the SEC Form 4 filings, Otello Stampacchia has made a total of 1 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 450,000 shares on October 14, 2020, which cost Otello Stampacchia around $9 Million.

Insider Trading History of Otello Stampacchia

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Otello Stampacchia Trading Performance

GuruFocus tracks the stock performance after each of Otello Stampacchia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Otello Stampacchia is -8.15%. GuruFocus also compares Otello Stampacchia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Otello Stampacchia within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Otello Stampacchia's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Otello Stampacchia

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.31
Relative Return to S&P 500(%) -6.14

Otello Stampacchia Ownership Network

Ownership Network List of Otello Stampacchia

No Data

Ownership Network Relation of Otello Stampacchia


Otello Stampacchia Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Otello Stampacchia is the director & 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Otello Stampacchia made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .

In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Otello Stampacchia Mailing Address

Above is the net worth, insider trading, and ownership report for Otello Stampacchia. You might contact Otello Stampacchia via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.

Discussions on Otello Stampacchia

No discussions yet.